share_log

YS Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%), etc.

SEC announcement ·  Feb 15 16:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more